INDIANAPOLIS -- A recent federal appeals court ruling allows generic competition for the antidepressant drug Prozac, produced by Eli Lilly & Co. here., and many other prescriptions drugs are expected lose their patent protection in coming years, which would trigger lower prices for an array of medications, observers noted. omising cheaper, generic prices and increasing government pressure on drug-makers for more inexpensive medications, according to press reports. "The cost of treating ...

REGISTER TO VIEW THIS ARTICLE - Register for a Free Account

Why Register for FREE?

Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick.  What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
 

Click here to read the FAQ page if you have any questions (opens in a new window)
 

Attention Paid Print Subscribers:  While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.

Already registered? here.